← Back to Newsletter Archive

Greetings!

Welcome to the Monthly QPS Preclinical Newsletter


Check the QPS antiviral assay list for the assay you need, learn more about preclinical wound-healing studies in mini-pigs, plus stay informed with the latest scientific insights and industry trends from the QPS Blog.



Find the Right Assay for Your Antiviral Program

Strengthen your antiviral program with QPS’ validated assays, including established LC-MS/MS methods.


Explore the QPS Assay Finder to identify available methods, assay ranges, matrices and sample requirements to help streamline study planning and accelerate development.

Explore the White Paper

Targeting Antiviral Mechanisms of Action

Generate Wound-Healing Data with Confidence

Confidently generate wound-healing data with QPS’ preclinical toxicology expertise. Our mini pig models help you evaluate dermal toxicity, irritation, sensitization and wound closure, supported by veterinary monitoring and expert histopathology.


With reliable, clinically relevant insights, you can make informed decisions and confidently move your topical therapy, wound dressing or dermatologic product toward the next development stage.

Get Started Today

Discover the Future of Science on the QPS Blog

Stopping Genetic Expansion Could Transform Huntington’s Disease and More



For years, drug development for Huntington’s disease has focused on reducing the toxic huntingtin protein produced by the mutant HTT gene. That strategy remains…


A New Development Strategy Takes Shape

Gene Therapy at QPS

Disarming the Gut Toxin Behind Colon Cancer


Colorectal cancer is a stealthy killer, causing as many as 900,000 deaths each year, per the most recent World Health Organization data. As the…


Leveraging the Findings for a Cancer-Prevention Drug

Oncology Clinical Trials at QPS

Contact the Experts at QPS

 

Request a meeting with QPS preclinical, bioanalysis, translational medicine, and/or clinical research subject matter experts today to explore how we can help accelerate your next drug development program.

Visit our website www.qps.com 

or contact us at infopr@qps.com

to start your next study.

 
Linkedin  Youtube  X  Facebook

View as Webpage

www.qps.com | infopr@qps.com

We use your email address exclusively for sending QPS newsletters with a special e-mail program. If you no longer wish to receive any mailings, simply use the "unsubscribe" link at the bottom. If you don't unsubscribe, we assume that this consent also applies to the system of the GDPR. (Data protection notice: According to Art. 7 GDPR, the consent can of course also be withdrawn at any time after May 25, 2018.)
← Back to Newsletter Archive